Komori
Earnings7600Japan Medical Dynamic Marketing,INC.Electrical Equipment and Precision Instruments

Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)

For the fiscal year ending March 2026, revenue declined, while operating profit and ordinary profit also fell sharply. However, due to the reversal of the previous fiscal year's extraordinary loss, net income attributable to owners of the parent turned profitable from a loss.

Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
63.1
%
Wording
Conditional
How definitive the wording is.

Results for this period

Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAP
Net Sales23,917Millions of yenYear on year -4.8%Progress 94.3%
Operating profit574Millions of yenYear on year -63.1%Progress 133.5%
Ordinary income534Millions of yenYear on year -64.1%Progress 381.4%
Net income attributable to owners of the parent263Millions of yenProgress 438.3%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥9.99
Operating Margin2.4%
Financial position at period-end
Total assets35,678Millions of yen
of which net assets 25,427 Millions of yenEquity ratio 71.2%vs. prior year-end -2.1pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating+205
Investment-1,995
Financials+1,648
Net change-142

Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period3,107 Millions of yen
Segment revenue
Japan13,109,98246.0%-3.8%
United States15,412,04054.0%-0.6%
Segment profit
Japan717,767-9.6%
United States-84,461
Regional sales
Japan13,109,98254.8%-3.8%
United States10,807,02645.2%-5.9%
Outlook and shareholder returns
Full-year earnings forecast
Net Sales25,370 Millions of yen (YoY +6.1%)
Operating profit430 Millions of yen (YoY -25.1%)
Ordinary income140 Millions of yen (YoY -73.8%)
Net income60 Millions of yen (YoY -77.2%)
Annual Dividend Forecast¥17 → ¥17(0.0%)
Payout ratio746.5%
Shareholder Return PolicyTargeting a dividend payout ratio of at least 30%
Factors Behind Changes in Business Performance

In Japan, revenue declined due to the cancellation of adoption decisions and a decrease in the number of cases acquired following the reported incidents. In the United States, revenue declined because supply constraints caused by delivery delays for certain products reduced the number of cases. The cost of sales increased due to U.S. reciprocal tariffs and higher labor costs, while the stronger yen also reduced yen-denominated revenue.

Disclosure regarding the going concern assumption

No applicable matters.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationAdded: 0 companies; excluded: 0 companies
Material subsequent eventsNo applicable matters.
Impairment lossNo expense recognized in the current period
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Loss on Disposal of Fixed Assets ¥32,779 thousand, Loss from discontinuation of product sales ¥7,885 thousand
Depreciation and amortization¥1,613,860 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End26,475,880
Treasury Shares at Period-End122,344
Results for this period
ItemDetails
Fiscal Period ClassificationFull year
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2025–31 March 2026
Net Sales23,917 Millions of yen (YoY -4.8%)
Operating profit574 Millions of yen (YoY -63.1%)
Ordinary income534 Millions of yen (YoY -64.1%)
Profit attributable to owners of the parent263 Millions of yen
Net income per share¥9.99
Operating Margin2.4%
Equity ratioEnd of the current fiscal period 71.2% / End of previous period 73.3%
Total assets35,678 Millions of yen
Net assets25,427 Millions of yen
Cash flows from operating activities205 Millions of yen
Cash flows from investing activities-1,995 Millions of yen
Cash flows from financing activities1,648 Millions of yen
Cash and cash equivalents at end of period3,107 Millions of yen
Full-year earnings forecastNet Sales 25,370 Millions of yen (YoY +6.1%) / Operating profit 430 Millions of yen (YoY -25.1%) / Ordinary income 140 Millions of yen (YoY -73.8%) / Net income 60 Millions of yen (YoY -77.2%)
Annual Dividend Forecast¥17 → ¥17(0.0%)
Payout ratio746.5%
Shareholder Return PolicyTargeting a dividend payout ratio of at least 30%
Segment revenueJapan ¥13,109,982 thousand (YoY -3.8%) / United States ¥15,412,040 thousand (YoY -0.6%)
Segment profitJapan ¥717,767 thousand (YoY -9.6%) / United States ¥-84,461 thousand
Regional salesJapan ¥13,109,982 thousand (YoY -3.8%) / United States ¥10,807,026 thousand (YoY -5.9%)
Depreciation and amortization¥1,613,860 thousand
Impairment lossNo expense recognized in the current period
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Loss on Disposal of Fixed Assets ¥32,779 thousand, Loss from discontinuation of product sales ¥7,885 thousand
Disclosure regarding the going concern assumptionNo applicable matters.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationAdded: 0 companies; excluded: 0 companies
Material subsequent eventsNo applicable matters.
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End26,475,880
Treasury Shares at Period-End122,344
Factors Behind Changes in Business PerformanceIn Japan, revenue declined due to the cancellation of adoption decisions and a decrease in the number of cases acquired following the reported incidents. In the United States, revenue declined because supply constraints caused by delivery delays for certain products reduced the number of cases. The cost of sales increased due to U.S. reciprocal tariffs and higher labor costs, while the stronger yen also reduced yen-denominated revenue.
Items this document does not state (2)
Revision to Earnings ForecastOrders received and order backlog

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In Japan, a series of reported incidents led to the cancellation of adoption decisions and a decline in the number of cases acquired. In the United States, the number of cases declined due to supply constraints caused by delivery delays for certain products. In addition, procurement and manufacturing costs increased due to U.S. reciprocal tariffs and higher labor costs, and the stronger yen also had an impact.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated) | Japan Medical Dynamic Marketing,INC. (7600) timely disclosure | Komori